XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

2
Player Avatar siri22 (< 20) Submitted: 10/19/2011 3:11:39 PM : Outperform Start Price: $5.37 XNPT Score: -64.85

Below pre approval price?

Featured Broker Partners


Advertisement